How Can My MedSpa Show Up in AI Recommendations?

The shift: from “Botox near me” to “ask the AI”

Medical spas sit at the intersection of healthcare and consumer services — and patient acquisition has always depended on trust, referrals, and search visibility. But the way potential patients research aesthetic treatments is changing fast, and the starting point is migrating from traditional search to AI chatbots.

Google processes over 1 million searches per month for “Botox near me” alone, with “medspa near me,” “lip filler near me,” and “CoolSculpting near me” adding millions more (SEMrush, 2025). The American Med Spa Association (AmSpa) reports that 72% of medspa patients research treatments online before booking a consultation, and RealSelf data shows that the average aesthetic patient visits 3–5 websites during their research journey.

That online-first behavior is now colliding with the AI chatbot wave.

Gartner forecast in February 2024 that traditional search engine volume will drop 25% by 2026 due to AI chatbots and virtual agents. Among adults aged 25–44 — the core demographic for aesthetic treatments — AI chatbot adoption is accelerating: Pew Research Center found 43% of adults aged 18–29 had used an AI chatbot by early 2024, with adults 30–49 at 33%.

The queries are changing too. Instead of typing “Botox near me” into a search engine and getting a map pack of local medspas, a patient asks an AI chatbot: “What should I know before getting Botox?” or “What are the best medspa chains in the US?” or “How do I choose between Botox and Dysport?” The AI responds with a narrative answer — mentioning specific products and brands by name — and the patient follows that recommendation without ever seeing your practice in a search result.

The implications for medspas are particularly severe because aesthetic treatments are high-consideration purchases. A single Botox patient represents $1,500–$3,000+ in annual revenue from repeat visits. A filler patient represents $2,000–$5,000. A body contouring patient represents $3,000–$15,000. When AI steers these patients toward national chains or specific product brands without mentioning your practice, the revenue impact is immediate and compounding.

Who AI actually recommends for aesthetic treatments

Across the major AI platforms, using patient-intent prompts like “What are the best medspas?” “Where should I get Botox?” “What is the best place for laser hair removal?” and “How do I find a good medspa near me?” — the same names appear over and over:

* AI mention rates based on Metricus internal testing across the major AI platforms using patient-intent queries (2026). Rates reflect how often a brand or entity was named in response to aesthetic treatment and medspa discovery prompts.

The pattern is stark. Allergan Aesthetics — a division of AbbVie, with over $5.5 billion in annual aesthetics revenue (AbbVie 2024 annual report) — dominates AI responses because its product brands (Botox, Juvederm, CoolSculpting, Latisse) are synonymous with the treatments themselves. AI recommends the product rather than the provider.

National chains like Ideal Image (approximately 170 locations) and LaserAway (approximately 100 locations across 17 states) appear consistently because they generate massive web presence through multi-state operations, press coverage, and aggressive digital marketing. RealSelf, with over 10 million monthly visitors (SimilarWeb, 2025), functions as the dominant aesthetic marketplace and gets cited as a recommendation source.

Independent medical spas, which represent approximately 70–75% of the 8,000–10,000 medspas operating in the US (AmSpa Industry Study, 2025), are almost never mentioned by name. The AI knows Botox exists. It knows Ideal Image exists. It does not know your practice exists.

Why your medspa is invisible to AI

AI chatbots generate recommendations based on patterns in their training data — billions of web pages, medical publications, Reddit threads, review sites, and news articles. The brands that appear most frequently in that data are the ones AI recommends.

Consider the math:

• Allergan Aesthetics benefits from massive annual marketing spend, generating millions of web mentions across medical journals, news outlets, beauty publications, Reddit discussions, and provider directories.
• Ideal Image generates roughly 1.5–2.5 million monthly website visits (SimilarWeb, 2025) and has extensive media coverage, franchise-related content, and review site presence across 170+ locations.
• RealSelf receives approximately 10 million monthly visits and hosts millions of patient reviews, before/after photos, and treatment pages that AI models extensively index.
• The average independent medspa website receives 500–3,000 monthly visits, has 20–80 Google reviews, and appears on perhaps 5–10 third-party sites.

That’s a 500x–10,000x gap in web presence. And web presence is what AI systems learn from.

Three specific factors determine whether AI mentions your medspa:

1. Corpus frequency: How often your brand appears across the web. Allergan has tens of millions of mentions through Botox alone — the product is referenced in medical literature, beauty blogs, news articles, and social media at an extraordinary rate. Ideal Image has hundreds of thousands of mentions across review sites, employment listings, franchise discussions, and consumer media. A single-location medspa might have 100–500 total web mentions. The volume gap is enormous.
2. Source authority: AI weights authoritative sources more heavily. Allergan gets coverage in major medical journals, business publications, and national beauty outlets. National chains get featured in business media, local news affiliates, and industry publications. An independent medspa gets a mention in a local lifestyle blog — which AI may never index.
3. Content structure: The Princeton/Georgia Tech GEO study (2023) found that content with statistical citations and clear factual claims was up to 40% more likely to be cited by generative AI systems (Aggarwal et al., “GEO: Generative Engine Optimization,” 2023). Most medspa websites are heavy on aspirational imagery and light on the structured, data-rich content that AI can extract and cite — specific pricing, outcome statistics, provider credentials with training volumes, and treatment comparison data.

The aesthetic medicine industry has an additional challenge: AI tends to recommend products rather than providers. A patient asks “How do I get rid of forehead wrinkles?” and AI responds with “Botox is the most common treatment...” — mentioning the product and its manufacturer but not the practice that actually administers it. This product-over-provider bias means even well-known medspas struggle for AI visibility.

What AI gets wrong about medspa treatments

Even when AI does discuss aesthetic treatments or mention specific providers, it frequently gets critical facts wrong. In an industry where medical safety and patient expectations are paramount, accuracy isn’t optional.

The most common errors in AI responses about medspa businesses:

Pricing ranges

Medspa treatment pricing varies enormously by geography, provider experience, and product used. AI routinely gets this wrong in ways that damage patient expectations and provider credibility. Botox pricing ranges from $10 to $25 per unit depending on market, with the average treatment requiring 20–60 units — meaning actual treatment costs range from $200 to $1,500. AI often cites flat-rate national averages ($300–$600 per area) that don’t reflect per-unit pricing models (ASAPS Procedural Statistics, 2024). For dermal fillers, the gap is worse: a syringe of Juvederm ranges from $500 to $1,200+ depending on the specific product line and geographic market, but AI frequently provides a single number. CoolSculpting sessions range from $2,000 to $4,000 per area according to the American Society of Plastic Surgeons (ASPS), but AI often quotes outdated pricing models.

Treatment safety and contraindications

This is where AI errors become potentially dangerous. AI sometimes conflates treatment protocols — suggesting that Botox and fillers can be administered in the same session without noting that the approach depends on the specific areas being treated and the provider’s clinical judgment. AI occasionally omits critical contraindications: patients with autoimmune disorders require special consideration for injectable treatments, and certain medications (blood thinners, for example) affect treatment planning. The American Society for Aesthetic Plastic Surgery (ASAPS) emphasizes that treatment planning should be individualized, but AI provides generic protocols.

Provider credentials and scope of practice

Medspa regulations vary dramatically by state. In some states, only physicians can own medspas. In others, nurse practitioners or physician assistants can own and operate them independently. AI frequently provides generic credentialing advice (“make sure your provider is board-certified”) without specifying board-certified in what. A board-certified dermatologist, a board-certified plastic surgeon, and a board-certified family medicine physician all have different training relevant to aesthetic procedures. AmSpa reports that state medical board complaints related to medspas increased 28% between 2020 and 2024, making accurate provider credential information critical for patient safety.

Recovery times and expected results

AI routinely understates recovery times for more aggressive treatments. Laser skin resurfacing (ablative CO2 or erbium) requires 7–14 days of significant downtime (ASPS), but AI sometimes quotes “a few days.” Chemical peels range from zero downtime (superficial) to 2+ weeks (deep phenol peels), and AI frequently fails to distinguish between peel depths. For injectables, AI often omits the fact that filler results take 2–4 weeks to fully settle and that initial swelling can be significant, leading to unrealistic patient expectations.

Technology and device accuracy

The aesthetic device market evolves rapidly. AI training data often reflects outdated device generations or discontinued technologies. AI may recommend treatments using devices no longer considered standard of care, or fail to distinguish between substantially different technologies marketed under similar names. For example, older-generation laser hair removal technology has different efficacy profiles across skin types compared to current diode and Nd:YAG platforms, but AI frequently treats “laser hair removal” as a single homogeneous technology.

The $20 billion+ market AI is reshaping

The medical spa and aesthetic medicine market is massive, fast-growing, and increasingly consumer-driven:

• The US medical spa market exceeded $20 billion in 2025 and is projected to reach $45.5 billion by 2030, growing at a CAGR of 14.6% (Grand View Research, 2025).
• The global aesthetic medicine market surpassed $100 billion in 2025, encompassing injectables, laser treatments, body contouring, and skin rejuvenation (McKinsey & Company, “The Beauty Market in 2025,” 2025).
• Allergan Aesthetics (AbbVie) generated $5.5 billion in aesthetics revenue in 2024 (AbbVie annual report), with Botox alone accounting for over $2.7 billion in US sales.
• The neurotoxin market (Botox, Dysport, Xeomin, Jeuveau, Daxxify) alone reached approximately $4.8 billion in US revenue in 2024.
• AmSpa estimates 8,000–10,000 medspas are currently operating in the US (2025 Industry Study), up from approximately 5,400 in 2018 — a 65%+ increase in seven years.
• The average medspa generates $1.2–$2.5 million in annual revenue (AmSpa benchmarking data, 2025), with top performers exceeding $5 million.

The industry’s growth is driven by demographic tailwinds: millennials and Gen Z are entering the aesthetic treatment market earlier and in greater numbers than any previous generation. ASAPS reports that patients aged 19–34 now account for 24% of all minimally invasive aesthetic procedures, up from 18% in 2019. These younger patients are also the most likely to use AI chatbots for research.

Yet despite its size and growth, the medspa industry has a structural digital marketing gap. Independent medspas spend an average of 5–8% of revenue on marketing, compared to 12–15% for national chains with dedicated digital marketing teams. Most single-location medspas rely on a combination of paid ads, social media, word of mouth, and directory listings for patient acquisition — with little to no content strategy that would build AI visibility.

This creates the same dynamic across local service industries: a massive market with fragmented, small operators and a handful of well-funded national brands and product manufacturers with outsized web presence.

The local medspa vs. national chain problem

The tension between local medspas and national chains is the defining competitive dynamic in the industry — and AI is making it dramatically worse.

Consider how the competitive landscape works:

• Ideal Image operates approximately 170 locations across 34 states. It generates extensive web presence through multi-state operations, national advertising campaigns, employment listings, and consumer review volume across every major platform.
• LaserAway operates approximately 100 locations across 17 states, with celebrity partnerships and influencer marketing that generates millions of branded impressions.
• Sono Bello operates approximately 100 locations focused on body contouring with national television and digital advertising.
• SkinSpirit, with approximately 40 locations, has attracted private equity investment and is expanding rapidly, generating increasing web presence with each new market entry.

An independent medspa competing in any of these chains’ markets faces a fundamental AI visibility gap. The chain has 100–170 locations, each generating reviews, social mentions, and directory listings. The chain has national press coverage. The chain has a marketing team producing content at scale. The chain’s website has thousands of pages of indexed content.

On traditional search, local medspas could still compete: map results actively favor proximity, and a well-optimized local practice with strong reviews could outrank a national chain in local search. In AI chatbot responses, proximity is irrelevant. The same national brands appear whether a patient is in Beverly Hills or Boise.

The gap between traditional search and AI recommendations for medspas is particularly wide because AI has a product-brand bias. On traditional search, “Botox near me” returns local providers. On AI chatbots, “Tell me about Botox” returns information about the product, its manufacturer, and possibly national chains that advertise it — with no local provider in sight.

Treatment-specific visibility: the hidden gap

Most medspas focus on general brand awareness — their practice name, their location, their overall reputation. But AI visibility operates at the treatment level, and this is where the gap becomes most damaging.

When a patient asks AI “best place to get lip filler,” the AI does not simply look up which medspas exist. It assembles an answer from content about lip filler as a treatment category — which products are used (Juvederm, Restylane), which techniques are common (microcannula vs. needle), what outcomes to expect, and what risks exist. Only after covering the treatment does AI name a provider, and by that point, the provider it names is the one most associated with that specific treatment in training data.

This means your medspa needs visibility not just as a brand, but for each treatment you offer. A practice that is known for Botox might be completely invisible for CoolSculpting. A practice recognized for laser hair removal might have zero AI presence for dermal fillers. Each treatment category has its own AI visibility profile.

The treatment-specific gap is particularly severe for emerging treatments and newer technologies. If your medspa offers a treatment that has less web content overall (like PDO thread lifts, or newer neurotoxins like Daxxify), the AI training data for that treatment is thin. The brands AI does cite are the ones that published the earliest or most authoritative content about it. For established treatments with deep content (Botox, basic fillers), the competition for AI visibility is intense because every national chain and product manufacturer has extensive content. For newer treatments, the opportunity is larger because the corpus is smaller — but only if you know where the gaps are.

A Metricus AI visibility report surfaces this treatment-level data: what AI says when patients ask about each specific service your medspa offers, which competitors appear in those responses, and what content is driving those citations.

How patients actually choose a medspa — and what AI misses

Understanding what drives aesthetic patients reveals the depth of AI’s blindspot. RealSelf patient survey data (2024), AmSpa consumer research (2025), and ASAPS procedural statistics consistently identify these top decision factors:

1. Provider credentials and experience — 89% of patients rate provider qualifications as “very important” (RealSelf, 2024). Patients want to know the injector’s specific training, board certifications, and injection volume. AI provides generic advice about finding “a qualified provider” without helping patients evaluate specific practitioners.
2. Before-and-after results — 82% of patients want to see actual results before committing. RealSelf reports that before/after galleries are the #1 content type driving consultation bookings. AI cannot display visual results and rarely directs patients to specific provider galleries.
3. Pricing transparency — 78% of patients want clear pricing before consultation. The reality: medspa pricing is deliberately opaque at most practices (“call for a consultation”), which means AI has no accurate data to cite. This opacity hurts both the patient and the practice.
4. Location and convenience — 74% of patients want a medspa within 15–20 minutes of home or work (AmSpa, 2025). Aesthetic treatments often require multiple sessions and follow-up visits. AI gives national recommendations with no proximity filtering.
5. Reviews and reputation — 71% check online reviews across multiple platforms. RealSelf “Worth It” ratings, Google reviews, and Yelp reviews all factor into decisions. AI surfaces brands with the most aggregate online presence, not necessarily the best-reviewed local options.
6. Treatment-specific expertise — 67% of patients seek providers with specific expertise in their desired treatment (e.g., lip specialists, body contouring experts). AI rarely identifies treatment-specific specialists at the local level.
7. Consultation experience — 61% of patients cite the consultation experience as the final deciding factor. This is entirely offline and something AI cannot evaluate or convey.

The fundamental mismatch: aesthetic patients need hyper-local, credential-specific, visually-verifiable information. AI provides national, generic, text-based recommendations. This is the gap your medspa can fill — if AI knows you exist.

The compounding cost of inaction

AI visibility is not static. It degrades. In our data, the average brand’s AI visibility gap widens by approximately 10% every 90 days when left unaddressed. For medspas, this compounds in specific ways.

National chains publish content at scale. Ideal Image, LaserAway, and Sono Bello each have dedicated content teams producing treatment pages, blog posts, and patient education materials optimized for web presence. Every new piece of content strengthens their position in AI training data. Your medspa, focused on clinical operations, publishes a social media post or occasional blog article. The gap between their corpus and yours grows with every publishing cycle.

Product manufacturers amplify this effect. Allergan spends billions on marketing, generating continuous press coverage, clinical study citations, and brand mentions across the web. Galderma, with its recent IPO, is accelerating its content investment. Each model update absorbs this new content and reinforces existing brand associations. Your practice, which administers these same products with equal or greater skill, has no share of that manufacturer-driven visibility.

The patient behavior shift accelerates the compounding. McKinsey found that 31% of consumers used AI for health-related questions in 2025, up from 12% in 2023. For elective procedures where patients are comfortable self-researching, the figure is likely higher. Each patient who starts with AI and never discovers your practice is a patient you cannot win back through traditional marketing channels — because they made their consideration-set decision before they ever saw your Instagram, your paid ad, or your Google listing.

The cost of a single lost Botox patient: $1,500–$3,000 in annual recurring revenue, multiplied across 3–5 years of retention. A single filler patient: $2,000–$5,000. A body contouring patient: $3,000–$15,000. Even losing 5–10 patients per quarter to AI-driven invisible discovery compounds into hundreds of thousands in foregone revenue over three years.

80% of brands that implemented the top 3 fixes from a Metricus report saw measurable changes within 10 days. The window to act is now.

The case for auditing your AI visibility now

The aesthetic medicine market is at an inflection point. The convergence of several trends makes this the right time to act:

Consumer demand is surging. ASAPS reports a 54% increase in minimally invasive cosmetic procedures between 2019 and 2024. The neurotoxin market alone grew 19% year-over-year in 2024. Millennials and Gen Z are driving new patient volumes at rates the industry has never seen. This growing demand means more patients are researching treatments online — and increasingly through AI.

The competitive landscape is consolidating. Private equity investment in aesthetic medicine practices exceeded $2 billion in 2024 (PitchBook data), with PE-backed platforms acquiring independent practices at an accelerating pace. These PE-backed groups have the resources to invest in digital content and AI visibility strategies. Independent medspas that don’t build their own AI presence risk being permanently outpaced.

AI adoption is accelerating in healthcare decisions. Gartner’s prediction that traditional search volume will drop 25% by 2026 is already materializing in aesthetic treatment queries. The medspas that understand their AI visibility now — while competitors are still relying exclusively on paid ads and social media — will have a structural advantage that compounds over time.

For a medspa generating $2 million in annual revenue, even 5% of new patient acquisition shifting to AI means approximately $100,000 in annual revenue is influenced by AI recommendations. Over three years, that’s $300,000 in revenue at risk — from a single channel shift.

Multi-location medspa groups face an even larger calculation. A 10-location group with the same assumptions could see $1 million+ in annual revenue influenced by AI — with almost none of it flowing to their practices if AI doesn’t know they exist.

Frequently Asked Questions

Why does AI recommend Botox and Allergan products instead of my medspa?

AI chatbots generate recommendations based on training data from the web. Allergan Aesthetics generates millions of web mentions through its Botox, Juvederm, and CoolSculpting brands. National chains have thousands of pages of indexed content, press coverage, and review site mentions. The average independent medspa has a basic website with 5–15 pages and a few dozen Google reviews. This gap in web corpus frequency means AI recommends products and national brands by default, while local providers are invisible.

What does AI get wrong about medspa treatments and pricing?

AI frequently provides incorrect information about medspa services. Common errors include outdated pricing (AI often cites national averages that don’t reflect per-unit pricing models), incorrect safety information about treatment combinations, wrong recovery time estimates for procedures like laser resurfacing or chemical peels, and conflation of different filler products. In an industry where medical safety is paramount, AI errors about contraindications, downtime, and expected results can influence patients to make uninformed decisions.

How can a local medspa compete with national chains in AI recommendations?

Local medspas can improve AI visibility by understanding exactly what AI currently says about their practice and treatments. A Metricus AI visibility report identifies exact errors and citation gaps. You submit your webpage, and within 24 hours you get back what AI says, why it says it, and how to fix it, with one-click imports for every fix. 80% of brands that implemented the top 3 fixes saw measurable changes within 10 days.

How big is the medspa market and why does AI visibility matter for it?

The US medical spa market exceeded $20 billion in 2025 and is projected to reach $45 billion by 2030 (Grand View Research). There are approximately 8,000–10,000 medspas operating in the US. As consumer research shifts from traditional search to AI chatbots, the brands that AI recommends will capture a disproportionate share of new patient acquisition. Currently, AI recommendations are dominated by product manufacturers and national chains, while the vast majority of independent medspas are never mentioned.

How fast does a medspa’s AI visibility degrade if left unaddressed?

In our data, the average brand’s AI visibility gap widens by approximately 10% every 90 days when left unaddressed. For medspas, this compounds quickly: national chains publish content at scale, product manufacturers generate continuous press coverage, and each AI model update reinforces the brands it already knows while the brands it doesn’t know fall further behind.

Does my medspa need ongoing AI monitoring or a one-time report?

90% of Metricus users report they don’t need ongoing monitoring — they just need to know what to fix and how to fix it. A Metricus Snapshot identifies the specific errors, missing citations, and content gaps for your practice, delivered as a 15-25 page PDF plus drop-in files (llms.txt, schema markup, page copy) within 24 hours. Curated by AI experts. $499, one-time, no subscription. Useful report or refund.

Sources: American Society for Aesthetic Plastic Surgery procedural statistics (ASAPS, 2024); American Med Spa Association industry study and benchmarking data (AmSpa, 2025); Grand View Research US medical spa market report (2025); McKinsey & Company “The Beauty Market in 2025” (2025); McKinsey consumer health AI survey (2025); AbbVie 2024 annual report and Allergan Aesthetics revenue data; American Society of Plastic Surgeons treatment cost data (ASPS, 2024); RealSelf patient survey and marketplace data (2024); PitchBook PE investment data in aesthetic medicine (2024); Gartner search prediction (Feb 2024); Pew Research Center AI adoption survey (2024); SEMrush search volume data (2025); SimilarWeb traffic estimates (2025); Princeton/Georgia Tech GEO study (Aggarwal et al., “GEO: Generative Engine Optimization,” 2023). AI mention rates based on Metricus internal testing across the major AI platforms (2026).